Qube Research & Technologies (QRT)’s Transmedics TMDX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-47,859	Closed	-$2.98M	–	3887
2024 Q4	$2.98M	Sell	47,859 -3,395	-7%	-$316K	﹤0.01%	1721
2024 Q3	$8.05M	Sell	51,254 -47,519	-48%	-$7.32M	0.01%	1163
2024 Q2	$14.9M	Buy	98,773 +95,974	+3,429%	+$11.5M	0.02%	751
2024 Q1	$207K	Buy	+2,799	New	+$231K	﹤0.01%	3012
2023 Q4	–	Sell	-84,450	Closed	-$4.62M	–	4730
2023 Q3	$4.62M	Buy	84,450 +20,081	+31%	+$1.45M	0.01%	970
2023 Q2	$5.41M	Buy	64,369 +1,727	+3%	+$132K	0.02%	681
2023 Q1	$4.74M	Buy	62,642 +51,366	+456%	+$3.55M	0.02%	689
2022 Q4	$696K	Sell	11,276 -29,826	-73%	-$1.59M	﹤0.01%	1358
2022 Q3	$1.72M	Buy	+41,102	New	+$1.79M	0.01%	995

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TMDX Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 47,859 shares — an estimated $2.98M sold.

Qube Research & Technologies (QRT) first reported a position in TMDX in Q3 2022 and held it in 9 quarters. The position peaked at $14.9M in Q2 2024. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

Qube Research & Technologies (QRT) reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 47,859 Transmedics shares in Q1 2025, an estimated $2.98M.
Qube Research & Technologies (QRT) first reported a position in Transmedics in Q3 2022 and held it in 9 quarters.
Qube Research & Technologies (QRT)'s Transmedics position peaked at $14.9M in Q2 2024.
298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.